FDA and MHRA forge new regulatory collaboration initiative - Pharmaceutical Technology

The new initiative is intended to improve the global oversight of medical devices, AI, and innovative medicines and to streamline knowledge sharing efforts. The new initiative is intended to improve the global oversight of medical devices, AI, and innovative medicines and to streamline knowledge sharing efforts. MHRA CEO Lawrence Tallon and FDA deputy commissioner Grace Graham announced the new initiative at the DIA annual meeting in Philadelphia. Credit: Melnikov Dmitriy / Shutterstock.com The US Food and Drug Administration (FDA) and the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) will more formally collaborate to combine the agencies’ expertise, helping shape…

Source: Pharmaceutical Technology